Tapewire

Nasdaq · USD

SIBN

SI-BONE, Inc.

Export transactions ↓
Tapewire entity
2501
SEC CIK
0001459839
Parsed reports
479

Last 12 months

Inside the activity.

0 purchase rows · 106 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025019
Dec 202504
Jan 202609
Feb 2026024
Mar 202601
Apr 202605
May 2026012
Jun 202601
Jul 202605
Aug 2026016
Sep 202602
Oct 202608

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
August 01, 2019 Filed Aug 3, 2019 00:17 UTC
RECUPERO ANTHONY JChief Commercial Officer
Exercise / conversionCommon Stock 1,200 $4.32 $5,184.00
Disclosure

SEC source: 0001562180-19-004153 · primarydocument.xml · nonDerivative · entry 1

RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,054

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 25, 2019 Filed Jul 29, 2019 20:29 UTC
FRANCIS LAURAChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,518 $0.00 Strike: $4.32 $0.00
Disclosure

SEC source: 0001562180-19-004084 · primarydocument.xml · derivative · entry 3

FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 171,210

Underlying: Common Stock · 2,518 shares

Expires 2025-05-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.

Read SEC document
July 25, 2019 Filed Jul 29, 2019 20:29 UTC
FRANCIS LAURAChief Financial Officer
SaleCommon Stock 2,518 $19.34 $48,707.69
Disclosure

SEC source: 0001562180-19-004084 · primarydocument.xml · nonDerivative · entry 2

FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,039

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.17 to $19.52, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · balance_after: Includes 43,653 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
July 25, 2019 Filed Jul 29, 2019 20:29 UTC
FRANCIS LAURAChief Financial Officer
Exercise / conversionCommon Stock 2,518 $4.32 $10,877.76
Disclosure

SEC source: 0001562180-19-004084 · primarydocument.xml · nonDerivative · entry 1

FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 92,557

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 24, 2019 Filed Jul 25, 2019 21:18 UTC
FRANCIS LAURAChief Financial Officer
GrantCommon Stock 20,000 $0.00 $0.00
Disclosure

SEC source: 0001562180-19-004060 · primarydocument.xml · nonDerivative · entry 1

FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 90,039

F1 · shares: Reflects shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock. The shares subject to the restricted stock unit vest in equal quarterly installments over four years commencing on August 15, 2019, subject to the Reporting Person's continued service through each relevant vesting date.

F2 · balance_after: Includes 43,653 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
July 18, 2019 Filed Jul 19, 2019 18:04 UTC
DUNN JEFFREY WDirector · Chairman, President & CEO
SaleCommon Stock 1,436 $20.16 $28,947.75
Disclosure

SEC source: 0001562180-19-004000 · primarydocument.xml · nonDerivative · entry 1

DUNN JEFFREY W · CIK 0001035986 · Director · Chairman, President & CEO

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 99,997

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · balance_after: Includes 92,920 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
July 18, 2019 Filed Jul 19, 2019 18:04 UTC
FRANCIS LAURAChief Financial Officer
SaleCommon Stock 485 $20.00 $9,700.00
Disclosure

SEC source: 0001562180-19-003999 · primarydocument.xml · nonDerivative · entry 1

FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,039

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · balance_after: Includes 23,653 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
July 18, 2019 Filed Jul 19, 2019 14:03 UTC
Reckling W CarltonCMO and VP, Medical Affairs
SaleCommon Stock 153 $20.00 $3,060.00
Disclosure

SEC source: 0001562180-19-003996 · primarydocument.xml · nonDerivative · entry 3

Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,896

F4 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F1 · balance_after: Includes 8,925 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
July 18, 2019 Filed Jul 19, 2019 18:04 UTC
Yerby Scott AChief Technology Officer
SaleCommon Stock 10,000 $20.01 $200,147.00
Disclosure

SEC source: 0001562180-19-004001 · primarydocument.xml · nonDerivative · entry 2

Yerby Scott A · CIK 0001754756 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 122,873

F3 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F4 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.14, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F5 · ownership.nature: Shares held by The Yerby Family Trust Dated May 22, 2007

Read SEC document
July 18, 2019 Filed Jul 19, 2019 18:04 UTC
Yerby Scott AChief Technology Officer
SaleCommon Stock 217 $20.00 $4,340.00
Disclosure

SEC source: 0001562180-19-004001 · primarydocument.xml · nonDerivative · entry 1

Yerby Scott A · CIK 0001754756 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,767

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · balance_after: Includes 8,925 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
July 18, 2019 Filed Jul 19, 2019 18:03 UTC
PISETSKY MICHAEL A.GC & Chief Compliance Officer
SaleCommon Stock 242 $20.00 $4,840.00
Disclosure

SEC source: 0001562180-19-003997 · primarydocument.xml · nonDerivative · entry 1

Pisetsky Michael A · CIK 0001754765 · GC & Chief Compliance Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,831

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · balance_after: Includes 9,975 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
July 18, 2019 Filed Jul 19, 2019 18:03 UTC
RECUPERO ANTHONY JChief Commercial Officer
SaleCommon Stock 419 $20.00 $8,380.00
Disclosure

SEC source: 0001562180-19-003998 · primarydocument.xml · nonDerivative · entry 1

RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,854

F1 · kind: The sale reported on this Form 4 represents shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. The sale satisfies the tax withholding obligations to be funded by a "sell to cover" transaction and does not represent a discretionary trade by the Reporting Person.

F2 · balance_after: Includes 17,237 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
July 17, 2019 Filed Jul 19, 2019 14:03 UTC
Reckling W CarltonCMO and VP, Medical Affairs
Exercise / conversionStock Option (Right to Buy) · Derivative 5,000 $0.00 Strike: $3.96 $0.00
Disclosure

SEC source: 0001562180-19-003996 · primarydocument.xml · derivative · entry 4

Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,000 shares

Expires 2023-03-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.

Read SEC document
July 17, 2019 Filed Jul 19, 2019 14:03 UTC
Reckling W CarltonCMO and VP, Medical Affairs
SaleCommon Stock 5,000 $20.01 $100,058.00
Disclosure

SEC source: 0001562180-19-003996 · primarydocument.xml · nonDerivative · entry 2

Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,049

F2 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F3 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.09, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F1 · balance_after: Includes 8,925 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
July 17, 2019 Filed Jul 19, 2019 14:03 UTC
Reckling W CarltonCMO and VP, Medical Affairs
Exercise / conversionCommon Stock 5,000 $3.96 $19,800.00
Disclosure

SEC source: 0001562180-19-003996 · primarydocument.xml · nonDerivative · entry 1

Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,049

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 8,925 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
July 15, 2019 Filed Jul 17, 2019 22:15 UTC
Yerby Scott AChief Technology Officer
SaleCommon Stock 10,133 $19.61 $198,729.41
Disclosure

SEC source: 0001562180-19-003981 · primarydocument.xml · nonDerivative · entry 1

Yerby Scott A · CIK 0001754756 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · by Trust

Disclosed balance after: 132,873

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $18.89 to $19.93, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Shares held by The Yerby Family Trust Dated May 22, 2007

Read SEC document
July 08, 2019 Filed Jul 10, 2019 18:18 UTC
Yerby Scott AChief Technology Officer
SaleCommon Stock 648 $19.01 $12,318.48
Disclosure

SEC source: 0001562180-19-003911 · primarydocument.xml · nonDerivative · entry 1

Yerby Scott A · CIK 0001754756 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 143,006

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F2 · ownership.nature: Shares held by The Yerby Family Trust Dated May 22, 2007

Read SEC document
July 02, 2019 Filed Jul 2, 2019 21:14 UTC
Yerby Scott AChief Technology Officer
SaleCommon Stock 376 $20.14 $7,572.64
Disclosure

SEC source: 0001562180-19-003788 · primarydocument.xml · nonDerivative · entry 2

Yerby Scott A · CIK 0001754756 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 143,654

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F3 · ownership.nature: Shares held by The Yerby Family Trust Dated May 22, 2007

Read SEC document
July 01, 2019 Filed Jul 2, 2019 21:15 UTC
RECUPERO ANTHONY JChief Commercial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 1,500 $0.00 Strike: $4.32 $0.00
Disclosure

SEC source: 0001562180-19-003789 · primarydocument.xml · derivative · entry 6

RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 119,590

Underlying: Common Stock · 1,500 shares

Expires 2026-07-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option vest as to 25% on the 12-month anniversary of vesting commencement date, and 1/36th of the balance of the shares vest each month thereafter, subject to Reporting Person's continued service through each relevant vesting date.

Read SEC document
July 01, 2019 Filed Jul 2, 2019 21:15 UTC
RECUPERO ANTHONY JChief Commercial Officer
SaleCommon Stock 1,500 $20.12 $30,185.85
Disclosure

SEC source: 0001562180-19-003789 · primarydocument.xml · nonDerivative · entry 4

RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,273

F2 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F3 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $19.84 to $20.56, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F1 · balance_after: Includes 18,469 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
July 01, 2019 Filed Jul 2, 2019 21:15 UTC
RECUPERO ANTHONY JChief Commercial Officer
Exercise / conversionCommon Stock 1,500 $4.32 $6,480.00
Disclosure

SEC source: 0001562180-19-003789 · primarydocument.xml · nonDerivative · entry 3

RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,773

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 18,469 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
June 28, 2019 Filed Jul 2, 2019 17:15 UTC
Reckling W CarltonCMO and VP, Medical Affairs
Exercise / conversionStock Option (right to buy) · Derivative 1,111 $0.00 Strike: $0.84 $0.00
Disclosure

SEC source: 0001562180-19-003790 · primarydocument.xml · derivative · entry 6

Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 1,111 shares

Expires 2020-09-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on the vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.

Read SEC document
June 28, 2019 Filed Jul 2, 2019 17:15 UTC
Reckling W CarltonCMO and VP, Medical Affairs
Exercise / conversionStock Option (right to buy) · Derivative 13,889 $0.00 Strike: $3.96 $0.00
Disclosure

SEC source: 0001562180-19-003790 · primarydocument.xml · derivative · entry 5

Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 55,554

Underlying: Common Stock · 13,889 shares

Expires 2023-03-18

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option vest in equal monthly installments over four years commencing on the vesting commencement date, subject to Reporting Person's continued service through each relevant vesting date.

Read SEC document
June 28, 2019 Filed Jul 2, 2019 17:15 UTC
Reckling W CarltonCMO and VP, Medical Affairs
SaleCommon Stock 1,111 $20.00 $22,220.00
Disclosure

SEC source: 0001562180-19-003790 · primarydocument.xml · nonDerivative · entry 4

Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,049

F2 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F1 · balance_after: Includes 9,562 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock.

Read SEC document
June 28, 2019 Filed Jul 2, 2019 17:15 UTC
Reckling W CarltonCMO and VP, Medical Affairs
SaleCommon Stock 13,889 $20.00 $277,780.00
Disclosure

SEC source: 0001562180-19-003790 · primarydocument.xml · nonDerivative · entry 3

Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,160

F2 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F1 · balance_after: Includes 9,562 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock.

Read SEC document
June 28, 2019 Filed Jul 2, 2019 17:15 UTC
Reckling W CarltonCMO and VP, Medical Affairs
Exercise / conversionCommon Stock 13,889 $3.96 $55,000.44
Disclosure

SEC source: 0001562180-19-003790 · primarydocument.xml · nonDerivative · entry 2

Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,049

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 9,562 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock.

Read SEC document
June 28, 2019 Filed Jul 2, 2019 17:15 UTC
Reckling W CarltonCMO and VP, Medical Affairs
Exercise / conversionCommon Stock 1,111 $0.84 $937.91
Disclosure

SEC source: 0001562180-19-003790 · primarydocument.xml · nonDerivative · entry 1

Reckling W Carlton · CIK 0001755111 · CMO and VP, Medical Affairs

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 11,160

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 9,562 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive on shares of the Issuer's common stock.

Read SEC document
June 28, 2019 Filed Jul 2, 2019 21:15 UTC
RECUPERO ANTHONY JChief Commercial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 900 $0.00 Strike: $4.32 $0.00
Disclosure

SEC source: 0001562180-19-003789 · primarydocument.xml · derivative · entry 5

RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,090

Underlying: Common Stock · 900 shares

Expires 2026-07-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option vest as to 25% on the 12-month anniversary of vesting commencement date, and 1/36th of the balance of the shares vest each month thereafter, subject to Reporting Person's continued service through each relevant vesting date.

Read SEC document
June 28, 2019 Filed Jul 2, 2019 21:15 UTC
RECUPERO ANTHONY JChief Commercial Officer
SaleCommon Stock 900 $20.00 $18,000.00
Disclosure

SEC source: 0001562180-19-003789 · primarydocument.xml · nonDerivative · entry 2

RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,273

F2 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F1 · balance_after: Includes 18,469 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
June 28, 2019 Filed Jul 2, 2019 21:15 UTC
RECUPERO ANTHONY JChief Commercial Officer
Exercise / conversionCommon Stock 900 $4.32 $3,888.00
Disclosure

SEC source: 0001562180-19-003789 · primarydocument.xml · nonDerivative · entry 1

RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,173

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 18,469 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
June 28, 2019 Filed Jul 2, 2019 21:14 UTC
Yerby Scott AChief Technology Officer
SaleCommon Stock 30,000 $20.00 $600,003.00
Disclosure

SEC source: 0001562180-19-003788 · primarydocument.xml · nonDerivative · entry 1

Yerby Scott A · CIK 0001754756 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 144,030

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $20.00 to $20.015, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F3 · ownership.nature: Shares held by The Yerby Family Trust Dated May 22, 2007

Read SEC document
June 25, 2019 Filed Jun 28, 2019 17:44 UTC
FRANCIS LAURAChief Financial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 2,518 $0.00 Strike: $4.32 $0.00
Disclosure

SEC source: 0001562180-19-003671 · primarydocument.xml · derivative · entry 3

FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 173,728

Underlying: Common Stock · 2,518 shares

Expires 2025-05-25

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The shares subject to the option vest as to 25% on the 12-month anniversary of vesting commencement date, and 1/36th of the balance of the shares vest each month thereafter, subject to Reporting Person's continued service through each relevant vesting date.

Read SEC document
June 25, 2019 Filed Jun 28, 2019 17:44 UTC
FRANCIS LAURAChief Financial Officer
SaleCommon Stock 2,518 $17.92 $45,114.75
Disclosure

SEC source: 0001562180-19-003671 · primarydocument.xml · nonDerivative · entry 2

FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,524

F2 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F3 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $17.42 to $18.25, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

F1 · balance_after: Includes 25,078 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
June 25, 2019 Filed Jun 28, 2019 17:44 UTC
FRANCIS LAURAChief Financial Officer
Exercise / conversionCommon Stock 2,518 $4.32 $10,877.76
Disclosure

SEC source: 0001562180-19-003671 · primarydocument.xml · nonDerivative · entry 1

FRANCIS LAURA · CIK 0001218802 · Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 73,042

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 25,078 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
June 18, 2019 Filed Jun 19, 2019 21:34 UTC
Yerby Scott AChief Technology Officer
SaleCommon Stock 4,433 $17.66 $78,269.05
Disclosure

SEC source: 0001562180-19-003594 · primarydocument.xml · nonDerivative · entry 2

Yerby Scott A · CIK 0001754756 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 174,030

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F4 · price: The price reported in Column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $17.55 to $17.90, inclusive.

F3 · ownership.nature: Shares held by The Yerby Family Trust Dated May 22, 2007

Read SEC document
June 17, 2019 Filed Jun 19, 2019 21:34 UTC
Yerby Scott AChief Technology Officer
SaleCommon Stock 5,700 $17.41 $99,259.80
Disclosure

SEC source: 0001562180-19-003594 · primarydocument.xml · nonDerivative · entry 1

Yerby Scott A · CIK 0001754756 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Trust

Disclosed balance after: 178,463

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F2 · price: The price reported in column 4 is a weighted-average price. The shares were sold in multiple transactions ranging from $17.22 to $17.60, inclusive. The Reporting Person undertakes to provide the Issuer, any securityholder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in these footnotes.

F3 · ownership.nature: Shares held by The Yerby Family Trust Dated May 22, 2007

Read SEC document
June 13, 2019 Filed Jun 17, 2019 22:36 UTC GrantStock Options (Right to buy) · Derivative 15,741 $0.00 Strike: $17.72 $0.00
Disclosure

SEC source: 0001562180-19-003566 · primarydocument.xml · derivative · entry 1

Davis Timothy E JR · CIK 0001492082 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,741

Underlying: Common Stock · 15,741 shares

Expires 2029-06-12

F1 · derivative.exercise_date: The shares subject to the option will vest in a series of 12 equal monthly increments over the one-year period following the Vesting Commencement Date, such that the option will be fully vested on the first anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Issuer's Board of Directors on each such applicable vesting date.

Read SEC document
June 13, 2019 Filed Jun 17, 2019 22:37 UTC GrantStock Options (Right to buy) · Derivative 15,741 $0.00 Strike: $17.72 $0.00
Disclosure

SEC source: 0001562180-19-003569 · primarydocument.xml · derivative · entry 1

Valentine Keith · CIK 0001289408 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,741

Underlying: Common Stock · 15,741 shares

Expires 2029-06-12

F1 · derivative.exercise_date: The shares subject to the option will vest in a series of 12 equal monthly increments over the one-year period following the Vesting Commencement Date, such that the option will be fully vested on the first anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Issuer's Board of Directors on each such applicable vesting date.

Read SEC document
June 13, 2019 Filed Jun 17, 2019 23:41 UTC
Foley Mark JDirector
GrantStock Options (Right to buy) · Derivative 26,236 $0.00 Strike: $17.72 $0.00
Disclosure

SEC source: 0001562180-19-003577 · primarydocument.xml · derivative · entry 1

Foley Mark J · CIK 0001529196 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,236

Underlying: Common Stock · 26,236 shares

Expires 2029-06-12

F1 · derivative.exercise_date: The shares subject to the option will vest in a series of 36 equal monthly increments over three years starting on the Vesting Commencement Date, such that the shares subject to the option will be fully vested on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Issuer's Board of Directors on each applicable vesting date.

Read SEC document
June 13, 2019 Filed Jun 17, 2019 23:41 UTC GrantStock Options (Right to buy) · Derivative 26,236 $0.00 Strike: $17.72 $0.00
Disclosure

SEC source: 0001562180-19-003576 · primarydocument.xml · derivative · entry 1

Donigan Heyward R · CIK 0001602546 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,236

Underlying: Common Stock · 26,236 shares

Expires 2029-06-12

F1 · derivative.exercise_date: The shares subject to the option will vest in a series of 36 equal monthly increments over three years starting on the Vesting Commencement Date, such that the shares subject to the option will be fully vested on the third anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Issuer's Board of Directors on each applicable vesting date.

Read SEC document
June 13, 2019 Filed Jun 17, 2019 22:37 UTC
Freund John GordonDirector · 10% owner
GrantStock Options (Right to buy) · Derivative 15,741 $0.00 Strike: $17.72 $0.00
Disclosure

SEC source: 0001562180-19-003570 · primarydocument.xml · derivative · entry 1

Freund John Gordon · CIK 0001296771 · Director · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,741

Underlying: Common Stock · 15,741 shares

Expires 2029-06-12

F1 · derivative.exercise_date: The shares subject to the option will vest in a series of 12 equal monthly increments over the one-year period following the Vesting Commencement Date, such that the option will be fully vested on the first anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Issuer's Board of Directors on each such applicable vesting date.

Read SEC document
June 13, 2019 Filed Jun 17, 2019 22:37 UTC GrantStock Options (Right to buy) · Derivative 15,741 $0.00 Strike: $17.72 $0.00
Disclosure

SEC source: 0001562180-19-003567 · primarydocument.xml · derivative · entry 1

HINCKLEY GREGORY K · CIK 0001239182 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,741

Underlying: Common Stock · 15,741 shares

Expires 2029-06-12

F1 · derivative.exercise_date: The shares subject to the option will vest in a series of 12 equal monthly increments over the one-year period following the Vesting Commencement Date, such that the option will be fully vested on the first anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Issuer's Board of Directors on each such applicable vesting date.

Read SEC document
June 13, 2019 Filed Jun 17, 2019 22:37 UTC GrantStock Options (Right to buy) · Derivative 15,741 $0.00 Strike: $17.72 $0.00
Disclosure

SEC source: 0001562180-19-003568 · primarydocument.xml · derivative · entry 1

Licitra Karen A · CIK 0001754757 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,741

Underlying: Common Stock · 15,741 shares

Expires 2029-06-12

F1 · derivative.exercise_date: The shares subject to the option will vest in a series of 12 equal monthly increments over the one-year period following the Vesting Commencement Date, such that the option will be fully vested on the first anniversary of the Vesting Commencement Date, subject to the Reporting Person's continuous service as a member of the Issuer's Board of Directors on each such applicable vesting date.

Read SEC document
June 10, 2019 Filed Jun 12, 2019 20:40 UTC
RECUPERO ANTHONY JChief Commercial Officer
Exercise / conversionStock Option (Right to Buy) · Derivative 200 $0.00 Strike: $4.32 $0.00
Disclosure

SEC source: 0001562180-19-003510 · primarydocument.xml · derivative · entry 3

RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 121,990

Underlying: Common Stock · 200 shares

Expires 2026-07-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option vest as to 25% on the 12-month anniversary of vesting commencement date, and 1/36th of the balance of the shares vest each month thereafter, subject to Reporting Person's continued service through each relevant vesting date.

Read SEC document
June 10, 2019 Filed Jun 12, 2019 20:40 UTC
RECUPERO ANTHONY JChief Commercial Officer
SaleCommon Stock 200 $18.00 $3,600.00
Disclosure

SEC source: 0001562180-19-003510 · primarydocument.xml · nonDerivative · entry 2

RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,273

F2 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F1 · balance_after: Includes 18,469 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
June 10, 2019 Filed Jun 12, 2019 20:40 UTC
RECUPERO ANTHONY JChief Commercial Officer
Exercise / conversionCommon Stock 200 $4.32 $864.00
Disclosure

SEC source: 0001562180-19-003510 · primarydocument.xml · nonDerivative · entry 1

RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,473

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · balance_after: Includes 18,469 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
June 06, 2019 Filed Jun 10, 2019 20:51 UTC
Yerby Scott AChief Technology Officer
SaleCommon Stock 648 $17.19 $11,139.12
Disclosure

SEC source: 0001562180-19-003442 · primarydocument.xml · nonDerivative · entry 1

Yerby Scott A · CIK 0001754756 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,960

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F2 · balance_after: Includes 9,562 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
June 03, 2019 Filed Jun 5, 2019 20:24 UTC
Yerby Scott AChief Technology Officer
SaleCommon Stock 376 $16.62 $6,249.12
Disclosure

SEC source: 0001562180-19-003340 · primarydocument.xml · nonDerivative · entry 1

Yerby Scott A · CIK 0001754756 · Chief Technology Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,608

F1 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F2 · balance_after: Includes 9,562 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document
June 03, 2019 Filed Jun 5, 2019 20:23 UTC
RECUPERO ANTHONY JChief Commercial Officer
Exercise / conversionStock Options (Right to buy) · Derivative 1,000 $0.00 Strike: $4.32 $0.00
Disclosure

SEC source: 0001562180-19-003339 · primarydocument.xml · derivative · entry 3

RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 122,190

Underlying: Common Stock · 1,000 shares

Expires 2026-07-26

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The shares subject to the option vest as to 25% on the 12-month anniversary of vesting commencement date, and 1/36th of the balance of the shares vest each month thereafter, subject to Reporting Person's continued service through each relevant vesting date.

Read SEC document
June 03, 2019 Filed Jun 5, 2019 20:23 UTC
RECUPERO ANTHONY JChief Commercial Officer
SaleCommon Stock 1,000 $16.62 $16,620.00
Disclosure

SEC source: 0001562180-19-003339 · primarydocument.xml · nonDerivative · entry 2

RECUPERO ANTHONY J · CIK 0001210230 · Chief Commercial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 19,273

F2 · kind: The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan.

F1 · balance_after: Includes 18,469 shares issuable on settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one shares of the Issuer's common stock.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.